Feedback

Design, synthesis, antiviral activities of ferulic acid derivatives

Affiliation
School of Pharmacy ,Shandong University of Traditional Chinese Medicine ,Jinan ,Shandong ,China
Mao, Jin-long;
Affiliation
School of Pharmacy ,Shandong University of Traditional Chinese Medicine ,Jinan ,Shandong ,China
Wang, Lei;
Affiliation
School of Pharmacy ,Shandong University of Traditional Chinese Medicine ,Jinan ,Shandong ,China
Chen, Shu-jie;
Affiliation
School of Traditional Chinese Medicine ,Shandong University of Traditional Chinese Medicine ,Jinan ,Shandong ,China
Yan, Bin;
Affiliation
School of Traditional Chinese Medicine ,Shandong University of Traditional Chinese Medicine ,Jinan ,Shandong ,China
Xun, Li-ying;
Affiliation
School of Pharmacy ,Shandong University of Traditional Chinese Medicine ,Jinan ,Shandong ,China
Li, Rui-cheng;
Affiliation
School of Pharmacy ,Shandong University of Traditional Chinese Medicine ,Jinan ,Shandong ,China
Wang, Pei-chen;
Affiliation
School of Traditional Chinese Medicine ,Shandong University of Traditional Chinese Medicine ,Jinan ,Shandong ,China
Zhao, Qi-tao

A series of novel ferulic acid derivatives were designed and synthesized, and the twenty-one compounds were evaluated for their antiviral activities against Respiratory syncytial virus (RSV), herpes simplex virus type 1 (HSV-1), and enterovirus type 71 (EV71). These derivatives with the core structure of diphenyl acrylic acids had cis-trans isomers, which were confirmed by 1 H NMR, HPLC, and UV-vis spectra for the first time. The A5 had a selective effect against RSV but no work on herpes simplex virus type 1 and enterovirus type 71, which showed a therapeutic index (TI) of 32 and was significantly better than ferulic acid. The A5 had no scavenging effect on free radicals, but the A2 as the degradation of A5 showed an obvious scavenging effect on DPPH· and ABTS + ·. In addition, the A5 had no toxicity to endothelial cells and even showed a proliferative effect. Therefore, the A5 is worth further optimizing its structure as a lead compound and investigating the mechanism of inhibiting Respiratory syncytial virus.

Cite

Citation style:
Could not load citation form.

Access Statistic

Total:
Downloads:
Abtractviews:
Last 12 Month:
Downloads:
Abtractviews:

Rights

License Holder: Copyright © 2023 Mao, Wang, Chen, Yan, Xun, Li, Wang and Zhao.

Use and reproduction: